Global Health Preparedness Frameworks and Recombinant Vaccine Platforms: A Public Health Perspective on Regulations and System Readiness. [PDF]
Russo L +3 more
europepmc +1 more source
Construction, expression, and characterization of rSEA-EGF and in vitro evaluation of its antitumor activity against nasopharyngeal cancer [PDF]
He, Ying +9 more
core +2 more sources
Sex Differences in Response to Viral Vector Vaccines-Implications for Future Vaccine Design. [PDF]
Grewe I, Zoran T, Addo MM.
europepmc +1 more source
Protective antigens hidden in the bovine Clostridium vaccine. [PDF]
Qin H +12 more
europepmc +1 more source
Cytomegalovirus-Based Viral Vectors Elicit Robust Systemic and Tissue-Resident Immune Response Against SARS-CoV-2 Antigens. [PDF]
Cokarić Brdovčak M +9 more
europepmc +1 more source
Dual role of rVSV vectors in prophylactic and therapeutic innovation: a comprehensive bibliometric and clinical trial perspective. [PDF]
Chen Y +6 more
europepmc +1 more source
Brucellosis vaccine development: immunological mechanisms, animal models, and future directions. [PDF]
Zhang Y +5 more
europepmc +1 more source
Structural studies promote vaccine development: lessons from African swine fever virus. [PDF]
Zhang Y, Zhu L.
europepmc +1 more source
Fiber-2, not Fiber-1, is the principal protective immunogen of fowl adenovirus serotype 4: insights from a comparative efficacy study of chimeric virus-based inactivated vaccines. [PDF]
Yang P +14 more
europepmc +1 more source

